key: cord-0048133-v2n3p459
authors: Chambers, Emma S.; Akbar, Arne N.
title: Reply
date: 2020-07-25
journal: J Allergy Clin Immunol
DOI: 10.1016/j.jaci.2020.06.020
sha: 1d2426d0e6fe72914f092501fecf954b74e44d9e
doc_id: 48133
cord_uid: v2n3p459

nan

To the Editor:

Soffer et al 1 offer some interesting insights into long-term interventions that could improve inflammageing in older adults. We agree that altering diet to a more Mediterranean-based diet or improving the mental well-being through meditation can be beneficial for older adults in part due to decreasing inflammation, as indicated in their correspondence. Indeed, it is well known that acute and chronic stress have negative outcomes for the individuals and not just due to the impact on mental well-being.

A recent meta-analysis demonstrated that stress induced by loneliness, which is more common in the older population, lead to increased circulating levels of inflammatory cytokines such as IL-6. 2 As discussed by Soffer et al, 1 nutritional interventions (this includes vitamin D) can have beneficial effects on the immune system. Vitamin D is known to have a number of immunomodulatory properties including promoting regulatory T cells and reducing inflammatory cytokine production. 3, 4 Unpublished data (ES Chambers, M Vukmanovic-Stejic, M Noursadeghi, A Martineau, AN Akbar, et al, 2020) from our laboratory have shown that vitamin D supplementation can significantly improve cutaneous immunity in older adults.

However nutritional interventions and meditation require long-term changes in behavior/lifestyle. The focus of our review was on short-term interventions that could be used immediately to improve the immune response of older people. 5 There is an unmet clinical need for reducing inflammation in the short-term in older adults, to improve vaccine efficacy and to reduce detrimental inflammation associated with infections such as those caused by severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2). 6 Coronavirus disease 2019 (COVID-19) disproportionately affects older adults, causing severe disease and mortality due to excessive inflammation similar to a cytokine storm. 7 Indeed, newly emerging data suggest that short-term anti-inflammatory drugs such as glucocorticoids are showing great promise in reducing disease severity. 8 As indicated in our review, there is clearly an important need for therapeutics in combating inflammageing and immunity especially in older people in the short-term to overcome current issues. However, longer-term interventions, if time allows, are important too. 

Nonpharmacologic therapeutic possibilities for immunosenescence

The association between loneliness, social isolation and inflammation: a systematic review and meta-analysis

The impact of vitamin D on regulatory T cells

Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1

Can blocking inflammation enhance immunity during aging?

The trinity of COVID-19: immunity, inflammation and intervention

Clinical and immunological features of severe and moderate coronavirus disease 2019

First drug to reduce mortality in hospitalised patients with respiratory complications of COVID-19 found